160 related articles for article (PubMed ID: 21130490)
21. Comparison of the clinical performance of an HPV mRNA test and an HPV DNA test in triage of atypical squamous cells of undetermined significance (ASC-US).
Waldstrom M; Ornskov D
Cytopathology; 2012 Dec; 23(6):389-95. PubMed ID: 21933290
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
Ren C; Zhu Y; Yang L; Zhang X; Liu L; Ren C
Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
[TBL] [Abstract][Full Text] [Related]
23. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
[TBL] [Abstract][Full Text] [Related]
24. HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy.
Sørbye SW; Arbyn M; Fismen S; Gutteberg TJ; Mortensen ES
PLoS One; 2011; 6(10):e26022. PubMed ID: 21998748
[TBL] [Abstract][Full Text] [Related]
25. Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.
Kraus I; Molden T; Holm R; Lie AK; Karlsen F; Kristensen GB; Skomedal H
J Clin Microbiol; 2006 Apr; 44(4):1310-7. PubMed ID: 16597856
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of Combined Visual Inspection with Acetic Acid and Cervical Cytology Testing as a Primary Screening Tool for Cervical Cancer: a Systematic Review and Meta-Analysis.
Chanthavilay P; Mayxay M; Phongsavan K; Marsden DE; White LJ; Moore L; Reinharz D
Asian Pac J Cancer Prev; 2015; 16(14):5889-97. PubMed ID: 26320468
[TBL] [Abstract][Full Text] [Related]
27. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
[TBL] [Abstract][Full Text] [Related]
28. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
Zhang H; Varma KR; Han M; Matsko J; Zhao C
Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
[TBL] [Abstract][Full Text] [Related]
29. A review of the clinical performance of the Aptima HPV assay.
Haedicke J; Iftner T
J Clin Virol; 2016 Mar; 76 Suppl 1():S40-S48. PubMed ID: 26614686
[TBL] [Abstract][Full Text] [Related]
30. Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.
Varnai AD; Bollmann M; Bankfalvi A; Speich N; Schmitt C; Griefingholt H; Kovács K; Klozoris C; Bollmann R
Oncol Rep; 2008 Feb; 19(2):457-65. PubMed ID: 18202795
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test.
Benevolo M; Vocaturo A; Caraceni D; French D; Rosini S; Zappacosta R; Terrenato I; Ciccocioppo L; Frega A; Giorgi Rossi P
J Clin Microbiol; 2011 Jul; 49(7):2643-50. PubMed ID: 21525231
[TBL] [Abstract][Full Text] [Related]
32. The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening.
Heideman DA; Hesselink AT; van Kemenade FJ; Iftner T; Berkhof J; Topal F; Agard D; Meijer CJ; Snijders PJ
J Clin Microbiol; 2013 Nov; 51(11):3653-7. PubMed ID: 23985912
[TBL] [Abstract][Full Text] [Related]
33. Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.
Ratnam S; Coutlee F; Fontaine D; Bentley J; Escott N; Ghatage P; Gadag V; Holloway G; Bartellas E; Kum N; Giede C; Lear A
J Clin Microbiol; 2010 Aug; 48(8):2779-85. PubMed ID: 20573862
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I.
Wu R; Belinson SE; Du H; Na W; Qu X; Wu R; Liu Y; Wang C; Zhou Y; Zhang L; Belinson JL
Int J Gynecol Cancer; 2010 Nov; 20(8):1411-4. PubMed ID: 21051986
[TBL] [Abstract][Full Text] [Related]
35. Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions.
Dockter J; Schroder A; Hill C; Guzenski L; Monsonego J; Giachetti C
J Clin Virol; 2009 Jul; 45 Suppl 1():S55-61. PubMed ID: 19651370
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
37. Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study.
Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
BMJ Open; 2016 Aug; 6(8):e011981. PubMed ID: 27515759
[TBL] [Abstract][Full Text] [Related]
38. Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population.
Baasland I; Romundstad PR; Eide ML; Jonassen CM
PLoS One; 2019; 14(1):e0210997. PubMed ID: 30673759
[TBL] [Abstract][Full Text] [Related]
39. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
[TBL] [Abstract][Full Text] [Related]
40. Prospective evaluation of E6/E7 mRNA detection by the NucliSENS Easy Q HPV assay in a stepwise protocol.
Padalko E; Van Renterghem L; Bamelis M; De Mey A; Sturtewagen Y; Vastenavond H; Weyers S; Praet M
J Med Virol; 2013 Jul; 85(7):1242-9. PubMed ID: 23918543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]